Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/35747
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Quintana-Espinoza, Patricia | en_US |
dc.contributor.author | Martín-Acosta, Pedro | en_US |
dc.contributor.author | Amesty, Ángel | en_US |
dc.contributor.author | Martín Rodríguez, Patricia | en_US |
dc.contributor.author | Lorenzo-Castrillejo, Isabel | en_US |
dc.contributor.author | Fernández Pérez, Leandro Fco | en_US |
dc.contributor.author | Machín, Félix | en_US |
dc.contributor.author | Estévez-Braun, Ana | en_US |
dc.date.accessioned | 2018-05-08T09:43:31Z | - |
dc.date.available | 2018-05-08T09:43:31Z | - |
dc.date.issued | 2017 | en_US |
dc.identifier.issn | 0968-0896 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/35747 | - |
dc.description.abstract | A set of 5-ethynylarylnaphthalimides was synthesized by Sonogashira cross-coupling reactions and evaluated for antiproliferative and antitopoisomerase II in vitro activities. Furthermore docking studies of these molecules as DNA-intercalators were carried out and the in vivo DNA-damaging activity was also determined with the model organism Saccharomyces cerevisiae. From the obtained results three naphthalimides 6, 13 and 14 showed strong topoisomerase II inhibitory activity. These three molecules also presented good docking scores as DNA-intercalators using a self-complementary oligodeoxynucleotide d (ATGCAT)(2) as a model, and compounds 13 and 14 were among the most cytotoxic in the in vivo DNA-damaging activity. | en_US |
dc.language | eng | en_US |
dc.relation | "Evaluación Preclinica de Nuevas Estructuras Quimicas Diseñadas Para Inhibir la Ruta Oncogenica Jak-Stat O Como Moduladores Selectivos de Los Receptores Estrógenos" | en_US |
dc.relation | Desarrollo Preclínico de Nuevas Estructuras Bioactivas Moduladoras de Las Actividades Oncogénicas de Stat3/5 O de Los Receptores de Estrógenos | en_US |
dc.relation.ispartof | Bioorganic and Medicinal Chemistry | en_US |
dc.source | Bioorganic and Medicinal Chemistry[ISSN 0968-0896],v. 25, p. 1976-1983 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject.other | Naphthalimides | en_US |
dc.subject.other | Antiproliferative activity | en_US |
dc.subject.other | Topoisomerase II | en_US |
dc.subject.other | DNA damage | en_US |
dc.subject.other | Saccaromyces cereviciae | en_US |
dc.title | 5-Ethynylarylnaphthalimides as antitumor agents: synthesis and biological evaluation | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.bmc.2017.02.024 | en_US |
dc.identifier.scopus | 85013192456 | - |
dc.identifier.isi | 000396798900028 | - |
dc.contributor.authorscopusid | 55853678300 | - |
dc.contributor.authorscopusid | 57191668358 | - |
dc.contributor.authorscopusid | 14024036100 | - |
dc.contributor.authorscopusid | 36604772400 | - |
dc.contributor.authorscopusid | 35339523900 | - |
dc.contributor.authorscopusid | 6506777525 | - |
dc.contributor.authorscopusid | 6602804373 | - |
dc.contributor.authorscopusid | 6701825073 | - |
dc.identifier.eissn | 1464-3391 | - |
dc.description.lastpage | 1983 | en_US |
dc.identifier.issue | 6 | - |
dc.description.firstpage | 1976 | en_US |
dc.relation.volume | 25 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 10377211 | - |
dc.contributor.daisngid | 8232999 | - |
dc.contributor.daisngid | 3211275 | - |
dc.contributor.daisngid | 3922169 | - |
dc.contributor.daisngid | 4720340 | - |
dc.contributor.daisngid | 795544 | - |
dc.contributor.daisngid | 1106759 | - |
dc.contributor.daisngid | 425077 | - |
dc.contributor.wosstandard | WOS:Quintana-Espinoza, P | - |
dc.contributor.wosstandard | WOS:Martin-Acosta, P | - |
dc.contributor.wosstandard | WOS:Amesty, A | - |
dc.contributor.wosstandard | WOS:Martin-Rodriguez, P | - |
dc.contributor.wosstandard | WOS:Lorenzo-Castrillejo, I | - |
dc.contributor.wosstandard | WOS:Fernandez-Perez, L | - |
dc.contributor.wosstandard | WOS:Machin, F | - |
dc.contributor.wosstandard | WOS:Estevez-Braun, A | - |
dc.date.coverdate | Enero 2017 | en_US |
dc.identifier.ulpgc | Sí | es |
dc.description.sjr | 0,871 | |
dc.description.jcr | 2,881 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q2 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Morfología | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-2378-3242 | - |
crisitem.author.orcid | 0000-0001-7802-465X | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Martín Rodríguez, Patricia | - |
crisitem.author.fullName | Fernández Pérez, Leandro Francisco | - |
crisitem.project.principalinvestigator | Fernández Pérez, Leandro Francisco | - |
crisitem.project.principalinvestigator | Fernández Pérez, Leandro Francisco | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.